BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2065547)

  • 1. Diagnostic significance of gastric cancer associated antigens (MG-AGS) in serum, ascitic fluid and gastric juice.
    Zhang JR; Zhang XY; Chen XT; Mu ZX; Hu JL; Fan DM
    Chin Med J (Engl); 1991 Apr; 104(4):300-2. PubMed ID: 2065547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization and detection of cancer-associated antigens in patients with gastric cancer].
    Yuan M
    Zhonghua Yi Xue Za Zhi; 1993 Aug; 73(8):457-61, 509. PubMed ID: 7509252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
    Zhang JR; Zhang XY; Chen XT
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of cancer-associated antigen in feces of patients with gastric cancer by monoclonal antibodies].
    Yuan M
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):103-5. PubMed ID: 1879286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in gastrointestinal cancer and its clinical significance].
    Taguchi T; Ota J; Sumida S; Rii M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of ferritin assay in peritoneal fluid and gastric juice].
    Krylov IuV; Malashenko SV; Medvedev MN; Mikhaĭlova EI
    Vopr Onkol; 2002; 48(1):88-90. PubMed ID: 12101576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of fecal detection of cancer-associated antigens using monoclonal antibodies in the diagnosis of colorectal cancer].
    Yuan M
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):497-500, 511-2. PubMed ID: 2086118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation].
    Arakawa Y; Kobayashi H; Ozaki T; Ariga H; Matsuo Y; Honda T; Arai T; Kurosu Y; Morita K; Konuma H
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of gastric cancer and premalignant lesions by novel marker glycoprotein 87 using monoclonal antibody Adnab-9.
    Qiao SX; Yuan M; Liu YL; Lin XS; Zhang XP; Tobi M
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1095-9. PubMed ID: 14578149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor marker in gastric cancer].
    Ohkura H; Sugano K
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():208-12. PubMed ID: 11424379
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique.
    Ren J; Chen Z; Juan SJ; Yong XY; Pan BR; Fan DM
    Cancer; 2000 Jan; 88(2):280-5. PubMed ID: 10640958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical utility of tumor markers in gastric and colon cancer].
    Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
    Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.